Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End‐Stage Kidney Disease
Background Heart failure with reduced ejection fraction (HFrEF) is a chronic disease with substantial mortality. Management of HFrEF has seen significant breakthrough after the launch of neprilysin inhibitor. The PARADIGM‐HF (Prospective Comparison of ARNI with ACEI to Determine Impacton Global Mort...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2022-09-01
|
| Schriftenreihe: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Schlagworte: | |
| Online-Zugang: | https://www.ahajournals.org/doi/10.1161/JAHA.122.026407 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|